{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:14:33Z","timestamp":1789787673651,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SUR\/2022\/004588"],"award-info":[{"award-number":["SUR\/2022\/004588"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jmgm.2025.109246","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:39:21Z","timestamp":1764895161000},"page":"109246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Identification of structural fragments and field point-based design of novel p38\u03b1 MAPK inhibitor: Integrating 2D and 3D-QSAR models with advanced in-silico techniques"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9096-8008","authenticated-orcid":false,"given":"Saurabh","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8894-066X","authenticated-orcid":false,"given":"Yogita","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2025.109246_bib1","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1002\/slct.202100406","article-title":"The p38 MAPK inhibitors and their role in inflammatory diseases","volume":"6","author":"Machado","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.jmgm.2025.109246_bib2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","article-title":"Diversity and versatility of p38 kinase signalling in health and disease","volume":"22","author":"Canovas","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmgm.2025.109246_bib3","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.3390\/molecules29184354","article-title":"p38\u03b1 mitogen-activated protein kinase\u2014an emerging drug target for the treatment of alzheimer's disease","volume":"29","author":"Detka","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109246_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108153","article-title":"Targeting the p38\u03b1 pathway in chronic inflammatory diseases: could activation, not inhibition, be the appropriate therapeutic strategy?","volume":"235","author":"Heng","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jmgm.2025.109246_bib5","article-title":"Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases","volume":"220","author":"Wang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmgm.2025.109246_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116950","article-title":"The journey of p38 MAP kinase inhibitors: from bench to bedside in treating inflammatory diseases","volume":"280","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s43018-024-00899-7","article-title":"First-in-class ultralong-target-residence-time p38\u03b1 inhibitors as a mitosis-targeted therapy for colorectal cancer","volume":"6","author":"Rudalska","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jmgm.2025.109246_bib8","article-title":"p38 mitogen\u2010activated protein kinase: functions and targeted therapy in diseases","volume":"2","author":"Zheng","year":"2023","journal-title":"MedComm \u2013 Oncol"},{"key":"10.1016\/j.jmgm.2025.109246_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113216","article-title":"Current status and future prospects of p38\u03b1\/MAPK14 kinase and its inhibitors","volume":"213","author":"Madkour","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133504","article-title":"QSAR modelling, molecular docking studies and ADMET predictions of polysubstituted pyridinylimidazoles as dual inhibitors of JNK3 and p38\u03b1 MAPK","volume":"1265","author":"\u017divadinovi\u0107","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109246_bib11","doi-asserted-by":"crossref","first-page":"20786","DOI":"10.1039\/D2NJ03686J","article-title":"Computer-aided drug design applied to a series of pyridinyl imidazole derivatives targeting p38\u03b1 MAP kinase: 2D-QSAR, docking, MD simulation, and ADMET investigations","volume":"46","author":"Aissouq","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11224-020-01668-9","article-title":"A selectivity study of polysubstituted pyridinylimidazoles as dual inhibitors of JNK3 and p38\u03b1 MAPK based on 3D-QSAR, molecular docking, and molecular dynamics simulation","volume":"32","author":"Fu","year":"2020","journal-title":"Struct. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.compbiomed.2019.05.023","article-title":"Dibenzepinones, dibenzoxepines and benzosuberones based p38\u03b1 MAP kinase inhibitors: their pharmacophore modelling, 3D-QSAR and docking studies","volume":"110","author":"Khan","year":"2019","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2025.109246_bib14","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2025.109246_bib15","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2025.109246_bib16","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1021\/jm8005417","article-title":"Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffold","volume":"51","author":"Herberich","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib17","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.bmcl.2010.01.059","article-title":"Part 2: structure\u2013activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38\u03b1 mitogen-activated protein kinase","volume":"20","author":"Wurz","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2025.109246_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/jm901392x","article-title":"Pyridinylquinoxalines and pyridinylpyridopyrazines as lead compounds for novel p38\u03b1 mitogen-activated protein kinase inhibitors","volume":"53","author":"Koch","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2011.11.019","article-title":"Structure-based design, synthesis and biological evaluation of N-pyrazole, N\u2032-thiazole urea inhibitors of MAP kinase p38\u03b1","volume":"48","author":"Getlik","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib20","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.bmcl.2011.05.114","article-title":"Indolin-2-one p38\u03b1 inhibitors I: design, profiling and crystallographic binding mode","volume":"21","author":"Eastwood","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2025.109246_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejmech.2015.03.008","article-title":"Design and synthesis of potent 1,2,4-trisubstituted imidazolinone derivatives with dual p38\u03b1MAPK and ERK1\/2 inhibitory activity","volume":"94","author":"Awadallah","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bmc.2017.12.031","article-title":"Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors","volume":"26","author":"Kaieda","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejmech.2019.04.035","article-title":"Pyridinylimidazoles as dual glycogen synthase kinase 3\u03b2\/p38\u03b1 mitogen-activated protein kinase inhibitors","volume":"175","author":"Heider","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/cmdc.201900129","article-title":"Structure\u2010based design, synthesis, and biological evaluation of Imidazo[4,5\u2010b]pyridin\u20102\u2010one\u2010Based p38 MAP kinase inhibitors: part 1","volume":"14","author":"Kaieda","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2025.109246_bib25","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/cmdc.201900373","article-title":"Structure\u2010based design, synthesis, and biological evaluation of Imidazo[4,5\u2010b]Pyridin\u20102\u2010one\u2010Based p38 MAP kinase inhibitors: part 2","volume":"14","author":"Kaieda","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2025.109246_bib26","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1021\/acs.jmedchem.0c00508","article-title":"Bioisosteric replacement of arylamide-linked spine residues with N-Acylhydrazones and selenophenes as a design strategy to novel dibenzosuberone derivatives as type I 1\/2 p38\u03b1 MAP kinase inhibitors","volume":"63","author":"Pedreira","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/ci050357s","article-title":"Molecular field extrema as descriptors of biological activity: definition and validation","volume":"46","author":"Cheeseright","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109246_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.172119","article-title":"The coefficient of conformism of a correlative prediction (CCCP): building up reliable nano-QSPRs\/QSARs for endpoints of nanoparticles in different experimental conditions encoded via quasi-SMILES","volume":"927","author":"Toropova","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jmgm.2025.109246_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s44371-025-00173-4","article-title":"2D-QSAR driven design, molecular docking, molecular dynamics simulation and MM\/GBSA studies on quinazoline derivatives for development of VEGFR-2 inhibitors","volume":"2","author":"Kashyap","year":"2025","journal-title":"Discov. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/1062936X.2024.2332203","article-title":"In silico insights into design of novel VEGFR-2 inhibitors: SMILES-based QSAR modelling, and docking studies on substituted benzo-fused heteronuclear derivatives","volume":"35","author":"Gupta","year":"2024","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jmgm.2025.109246_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0169-7439(93)85002-X","article-title":"SIMPLS: an alternative approach to partial least squares regression","volume":"18","author":"De Jong","year":"1993","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.jmgm.2025.109246_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/qsar.200610151","article-title":"Principles of QSAR models validation: internal and external","volume":"26","author":"Gramatica","year":"2007","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.jmgm.2025.109246_bib33","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1289\/ehp.5758","article-title":"Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs","volume":"111","author":"Eriksson","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jmgm.2025.109246_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00031305.1990.10475691","article-title":"A simplified derivation of the variance of Kendall's rank correlation coefficient","volume":"44","author":"Valz","year":"1990","journal-title":"Am. Stat."},{"key":"10.1016\/j.jmgm.2025.109246_bib35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/jm049575n","article-title":"Identification of novel p38\u03b1 MAP kinase inhibitors using fragment-based lead generation","volume":"48","author":"Gill","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108371","article-title":"Design of BBB permeable BACE-1 inhibitor as potential drug candidate for alzheimer disease: 2D-QSAR, molecular docking, ADMET, molecular dynamics, MMGBSA","volume":"116","author":"Kaur","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib37","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1021\/acs.jmedchem.2c00164","article-title":"Electrostatic complementarity in structure-based drug design","volume":"65","author":"Cons","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109246_bib38","doi-asserted-by":"crossref","DOI":"10.1063\/1.3519057","article-title":"A water-swap reaction coordinate for the calculation of absolute protein-ligand binding free energies","volume":"134","author":"Woods","year":"2011","journal-title":"J. Chem. Phys."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325003067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325003067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:32:25Z","timestamp":1773880345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325003067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"alternative-id":["S1093326325003067"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109246","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of structural fragments and field point-based design of novel p38\u03b1 MAPK inhibitor: Integrating 2D and 3D-QSAR models with advanced in-silico techniques","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109246"}}